Concepedia

Susanna Eketjäll

SE

26

Publications

2K

Citations

21

H-Index

1999

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Karolinska Institutet

Integrated Cardio Metabolic Centre

Science for Life Laboratory

Karolinska University Hospital

Susanna Eketjäll is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and neuroprotection.

ORCID

Top concepts

Publications per year

1999–2023

26

Publications

26

<scp>TREM</scp> 2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant

Peter Thornton, Jean Sévalle, Michael J. Deery et al. · EMBO Molecular Medicine · 2017 · 213 citations · Full text

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

Vilija Oke, Iva Gunnarsson, Jessica M. Dorschner et al. · Arthritis Research & Therapy · 2019 · 210 citations · Full text

Differential Effects of Glial Cell Line‐Derived Neurotrophic Factor and Neurturin on Developing and Adult Substantia Nigra Dopaminergic Neurons

Peter Åkerud, Jordi Alberch, Susanna Eketjäll et al. · Journal of Neurochemistry · 1999 · 173 citations

Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease

Fredrik Jeppsson, Susanna Eketjäll, Juliette Janson et al. · Journal of Biological Chemistry · 2012 · 134 citations · Full text

AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics

Susanna Eketjäll, Juliette Janson, Karin Kaspersson et al. · Journal of Alzheimer s Disease · 2016 · 128 citations · Full text

Rows per page

1–5 of 26